Both sides of the “low T” drug litigation in Philadelphia may have wanted the pending state court cases consolidated into a mass tort program, but their requests have been rejected by the judge overseeing the litigation.
Philadelphia Administrative Judge Jacqueline F. Allen on Tuesday denied the petition in In re Testosterone Replacement Therapy Products Liability Litigation, which had sought mass tort designation for the cases.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
